* Assembly Biosciences Inc ASMB.OQ reported a quarterly
adjusted loss of 55 cents per share for the quarter ended in
June. The mean expectation of six analysts for the quarter was
for a loss of 66 cents per share.
* Reported revenue was zero; analysts expected $1.51 million.
* Assembly Biosciences Inc's reported EPS for the quarter was a
loss of 55 cents.
* The mean earnings estimate of analysts had risen by
about 11.1% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Assembly Biosciences Inc shares had fallen by 6.7% this
quarter and lost 40.2% so far this year.
* The company reported a quarterly loss of $23.6 million.
* Wall Street's median 12-month price target for Assembly
Biosciences Inc is $13.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated August 5 at 10:12 p.m. All
figures in US dollars unless otherwise stated